Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
37
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| DOyley-Gay Hope | General Counsel | 4 | $0 | $0 | 2022-11-30 |
| Scaria Abraham | Chief Scientific Officer | 4 | $0 | $0 | 2022-11-30 |
| Schneider Susan | Chief Medical Officer | 4 | $0 | $0 | 2022-11-30 |
| Hashad Yehia | Director | 4 | $0 | $0 | 2022-11-30 |
| Reynolds Gerald Anthony | Chief Accounting Officer | 8 | $0 | $3.4K | 2022-11-30 |
| Robinson James A. Jr. | Director | 2 | $0 | $0 | 2022-11-30 |
| Rosen James | Director, 10% Owner | 28 | $757.8K | $0 | 2022-11-30 |
| Washer Susan B. | See Remarks | 32 | $7.9K | $21.7K | 2022-11-30 |
| Aliski William | Director | 14 | $19.5K | $0 | 2022-11-30 |
| Koenig Scott | Director | 22 | $0 | $0 | 2022-11-30 |
| Potter Stephen W | VP and Chief Business Officer | 28 | $12.4K | $6.2K | 2022-11-30 |
| Lieber Jonathan I | Chief Financial Officer | 4 | $0 | $0 | 2022-11-30 |
| VANLENT ANNE | Director | 15 | $0 | $0 | 2022-11-30 |
| HURWITZ EDWARD | Director | 22 | $0 | $0 | 2022-11-30 |
| Magovcevic-Liebisch Ivana | Director | 11 | $28.9K | $0 | 2021-11-30 |
| Shearman Mark S | Chief Scientific Officer | 13 | $26.6K | $10.1K | 2020-08-15 |
| Sullivan William A. | Chief Financial Officer | 5 | $10.0K | $0 | 2020-08-05 |
| Krol Patrick Johan Hendrik | 10% Owner | 1 | $0 | $425.3K | 2019-12-26 |
| Inspirational Visions B.V. | 10% Owner | 1 | $7.1K | $0 | 2019-11-19 |
| Krex Brian | General Counsel | 2 | $0 | $0 | 2019-08-15 |
| Heah Theresa | Chief Medical Officer | 1 | $0 | $0 | 2019-07-29 |
| Feinsod Matthew | Interim Chief Medical Officer | 48 | $0 | $0 | 2019-07-29 |
| BULLOCK LAWRENCE E | Chief Financial Officer | 6 | $87.5K | $0 | 2017-08-03 |
| Ashe Andrew D. | General Counsel | 1 | $0 | $0 | 2017-08-01 |
| Goldstein Michael H. | Chief Medical Officer | 2 | $0 | $0 | 2017-07-17 |
| ORONSKY ARNOLD L | Director, 10% Owner | 17 | $908.8K | $0 | 2017-04-24 |
| Chulay Jeffrey D. | VP and Chief Medical Officer | 14 | $0 | $7.0K | 2016-11-01 |
| PEACOCK BRUCE | Director | 2 | $0 | $0 | 2015-11-19 |
| GLAXOSMITHKLINE PLC | Other | 11 | $1.25M | $12.13M | 2015-02-23 |
| Menichella Daniel L | V.P. & Chief Business Officer | 8 | $0 | $237.2K | 2015-01-23 |
| Alta Partners Management VIII, LLC | 10% Owner | 1 | $0 | $0 | 2014-11-17 |
| Knop David R. | Director, Process Development | 2 | $0 | $0 | 2014-07-31 |
| Carroll Jill | Director, 10% Owner | 5 | $1.25M | $0 | 2014-04-01 |
| Wu Samuel | Director, 10% Owner | 8 | $908.8K | $0 | 2014-04-01 |
| MedImmune Ventures, Inc. | 10% Owner | 8 | $908.8K | $0 | 2014-04-01 |
| CASH HARVEY B | 10% Owner | 8 | $904.5K | $0 | 2014-04-01 |
| JANNEY DANIEL | 10% Owner | 5 | $1.87M | $0 | 2014-04-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 442,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 275,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 169,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 100,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 100,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 140,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 99,156 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 55,780 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 80,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 80,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | D To issuer deriv | 2022-11-30 | 2022-12-01 | 100,000 | — | $0 | 0 | SEC↗ |
| Lieber Jonathan I | Chief Financial Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 202,000 | — | $0 | 0 | SEC↗ |
| Lieber Jonathan I | Chief Financial Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 154,700 | — | $0 | 0 | SEC↗ |
| Schneider Susan | Chief Medical Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 142,300 | — | $0 | 0 | SEC↗ |
| Schneider Susan | Chief Medical Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 180,000 | — | $0 | 0 | SEC↗ |
| DOyley-Gay Hope | General Counsel | D To issuer deriv | 2022-11-30 | 2022-12-01 | 147,900 | — | $0 | 0 | SEC↗ |
| DOyley-Gay Hope | General Counsel | D To issuer deriv | 2022-11-30 | 2022-12-01 | 180,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 85,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 133,100 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 131,049 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 51,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 52,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 60,000 | — | $0 | 0 | SEC↗ |
| Scaria Abraham | Chief Scientific Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 220,000 | — | $0 | 0 | SEC↗ |
| Scaria Abraham | Chief Scientific Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 124,500 | — | $0 | 0 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 30,000 | — | $0 | 0 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 34,500 | — | $0 | 0 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | D To issuer deriv | 2022-11-30 | 2022-12-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,285 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 9,375 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 4,688 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 6,200 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Hashad Yehia | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Hashad Yehia | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 4,688 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 9,375 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 6,200 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 9,375 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 4,688 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 6,200 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 16,000 | — | $0 | 0 | SEC↗ |
| VANLENT ANNE | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | Director | D To issuer deriv | 2022-11-30 | 2022-12-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | U Tender | 2022-11-30 | 2022-12-01 | 143,021 | — | $0 | 0 | SEC↗ |
| Potter Stephen W | Chief Business Officer | U Tender | 2022-11-30 | 2022-12-01 | 47,133 | — | $0 | 8,750 | SEC↗ |
| Potter Stephen W | Chief Business Officer | D To issuer | 2022-11-30 | 2022-12-01 | 8,750 | — | $0 | 0 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | U Tender | 2022-11-30 | 2022-12-01 | 8,506 | — | $0 | 42,500 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | D To issuer | 2022-11-30 | 2022-12-01 | 42,500 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | U Tender | 2022-11-30 | 2022-12-01 | 34,246 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | U Tender | 2022-11-30 | 2022-12-01 | 1,800 | — | $0 | 0 | SEC↗ |
| HURWITZ EDWARD | Director | U Tender | 2022-11-30 | 2022-12-01 | 25,672 | — | $0 | 0 | SEC↗ |
| Aliski William | Director | U Tender | 2022-11-30 | 2022-12-01 | 8,500 | — | $0 | 0 | SEC↗ |
| Rosen James | Director | U Tender | 2022-11-30 | 2022-12-01 | 1,000 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2022-08-21 | 2022-08-24 | 442,000 | — | $0 | 442,000 | SEC↗ |
| Lieber Jonathan I | Chief Financial Officer | A Award deriv | 2022-08-21 | 2022-08-24 | 154,700 | — | $0 | 154,700 | SEC↗ |
| Schneider Susan | Chief Medical Officer | A Award deriv | 2022-08-21 | 2022-08-24 | 142,300 | — | $0 | 142,300 | SEC↗ |
| Scaria Abraham | Chief Scientific Officer | A Award deriv | 2022-08-21 | 2022-08-24 | 124,500 | — | $0 | 124,500 | SEC↗ |
| Potter Stephen W | Chief Business Officer | A Award deriv | 2022-08-21 | 2022-08-24 | 133,100 | — | $0 | 133,100 | SEC↗ |
| DOyley-Gay Hope | General Counsel | A Award deriv | 2022-08-21 | 2022-08-24 | 147,900 | — | $0 | 147,900 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | A Award | 2022-08-21 | 2022-08-24 | 30,000 | — | $0 | 51,006 | SEC↗ |
| Potter Stephen W | Chief Business Officer | S Sale | 2022-07-01 | 2022-07-01 | 8,070 | $0.77 | $6.2K | 55,883 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | S Sale | 2022-05-27 | 2022-05-31 | 3,994 | $0.85 | $3.4K | 21,006 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise deriv | 2022-02-18 | 2022-02-22 | 120,686 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise | 2022-02-18 | 2022-02-22 | 120,686 | $0.35 | $42.2K | 152,971 | SEC↗ |
| Washer Susan B. | President and CEO | S Sale | 2022-02-18 | 2022-02-22 | 9,950 | $2.18 | $21.7K | 143,021 | SEC↗ |
| DOyley-Gay Hope | General Counsel | A Award deriv | 2021-12-13 | 2021-12-15 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Scaria Abraham | Chief Scientific Officer | A Award deriv | 2021-12-06 | 2021-12-07 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Aliski William | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Hashad Yehia | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Magovcevic-Liebisch Ivana | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Robinson James A. Jr. | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Schneider Susan | Chief Medical Officer | A Award deriv | 2021-11-08 | 2021-11-16 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise deriv | 2021-11-01 | 2021-11-03 | 3,877 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise | 2021-11-01 | 2021-11-03 | 3,877 | $3.50 | $13.6K | 32,285 | SEC↗ |
| Lieber Jonathan I | Chief Financial Officer | A Award deriv | 2021-09-20 | 2021-09-21 | 202,000 | — | $0 | 202,000 | SEC↗ |
| Hashad Yehia | Director | A Award deriv | 2021-08-16 | 2021-08-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Potter Stephen W | Chief Business Officer | F Tax w/h | 2021-08-15 | 2021-08-17 | 5,724 | $3.58 | $20.5K | 63,953 | SEC↗ |
| Reynolds Gerald Anthony | Chief Accounting Officer | A Award deriv | 2021-08-05 | 2021-08-06 | 34,500 | — | $0 | 34,500 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2021-07-27 | 2021-07-29 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Potter Stephen W | Chief Business Officer | A Award deriv | 2021-07-27 | 2021-07-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Potter Stephen W | Chief Business Officer | A Award | 2021-06-17 | 2021-06-21 | 35,000 | — | $0 | 69,677 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Aliski William | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Magovcevic-Liebisch Ivana | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ | |
| VANLENT ANNE | Director | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | F Tax w/h | 2020-08-15 | 2020-08-18 | 5,723 | $5.77 | $33.0K | 33,277 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | F Tax w/h | 2020-08-15 | 2020-08-18 | 5,723 | $5.77 | $33.0K | 34,677 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2020-08-05 | 2020-08-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2020-08-05 | 2020-08-07 | 169,000 | — | $0 | 169,000 | SEC↗ |
| Sullivan William A. | Chief Financial Officer | A Award deriv | 2020-08-05 | 2020-08-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | A Award deriv | 2020-08-05 | 2020-08-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Krol Patrick Johan Hendrik | 10% Owner | S Sale | 2019-12-26 | 2019-12-30 | 81,162 | $5.24 | $425.3K | 1,780,762 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Aliski William | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Inspirational Visions B.V. | 10% Owner | P Buy | 2019-11-19 | 2019-11-26 | 2,544 | $2.79 | $7.1K | 1,861,924 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise deriv | 2019-09-18 | 2019-09-20 | 5,700 | — | $0 | 13,841 | SEC↗ |
| Washer Susan B. | President and CEO | M Exercise | 2019-09-18 | 2019-09-20 | 5,700 | $3.50 | $19.9K | 28,408 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2019-08-15 | 2019-08-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sullivan William A. | Chief Financial Officer | A Award deriv | 2019-08-15 | 2019-08-19 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | A Award deriv | 2019-08-15 | 2019-08-19 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2019-08-15 | 2019-08-19 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Krex Brian | General Counsel | A Award deriv | 2019-08-15 | 2019-08-19 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | A Award | 2019-08-15 | 2019-08-19 | 39,000 | — | $0 | 40,400 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award | 2019-08-15 | 2019-08-19 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Feinsod Matthew | Exec. VP, Global Strat. & De | A Award deriv | 2019-07-29 | 2019-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Heah Theresa | Chief Medical Officer | A Award deriv | 2019-07-29 | 2019-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-07-11 | 2019-07-15 | 592 | $3.75 | $2.2K | 56,052 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-07-11 | 2019-07-15 | 2,000 | — | $0 | 56,644 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-06-11 | 2019-06-13 | 2,000 | — | $0 | 55,329 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-06-11 | 2019-06-13 | 685 | $3.77 | $2.6K | 54,644 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-06-11 | 2019-06-20 | 685 | $3.70 | $2.5K | 54,644 | SEC↗ |
| Koenig Scott | Director | M Exercise deriv | 2019-05-28 | 2019-05-30 | 32,018 | — | $0 | 0 | SEC↗ |
| Koenig Scott | Director | M Exercise | 2019-05-28 | 2019-05-30 | 32,018 | $0.35 | $11.2K | 34,246 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-05-13 | 2019-05-15 | 2,000 | — | $0 | 54,014 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-05-13 | 2019-05-15 | 685 | $4.20 | $2.9K | 53,329 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-05-13 | 2019-05-20 | 685 | $4.06 | $2.8K | 53,329 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-04-11 | 2019-04-15 | 2,000 | — | $0 | 52,620 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-04-11 | 2019-04-15 | 606 | $4.61 | $2.8K | 52,014 | SEC↗ |
| Krex Brian | General Counsel | A Award deriv | 2019-03-25 | 2019-04-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-03-11 | 2019-03-13 | 2,000 | — | $0 | 51,287 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-03-11 | 2019-03-13 | 667 | $3.97 | $2.6K | 50,620 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-02-11 | 2019-02-13 | 791 | $3.29 | $2.6K | 49,287 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-02-11 | 2019-02-13 | 2,000 | — | $0 | 50,078 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2019-01-11 | 2019-01-15 | 713 | $3.20 | $2.3K | 48,078 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2019-01-11 | 2019-01-15 | 2,000 | — | $0 | 48,791 | SEC↗ |
| Washer Susan B. | President and CEO | P Buy | 2018-12-14 | 2018-12-18 | 2,380 | $3.34 | $7.9K | 22,708 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | S Sale | 2018-12-14 | 2018-12-18 | 3,000 | $3.35 | $10.1K | 0 | SEC↗ |
| Sullivan William A. | Chief Financial Officer | P Buy | 2018-12-14 | 2018-12-18 | 3,000 | $3.33 | $10.0K | 3,000 | SEC↗ |
| Aliski William | Director | P Buy | 2018-12-14 | 2018-12-18 | 1,200 | $3.24 | $3.9K | 3,700 | SEC↗ |
| Aliski William | Director | P Buy | 2018-12-14 | 2018-12-18 | 500 | $3.24 | $1.6K | 8,500 | SEC↗ |
| Aliski William | Director | P Buy | 2018-12-14 | 2018-12-18 | 4,300 | $3.25 | $14.0K | 8,000 | SEC↗ |
| Rosen James | Director | P Buy | 2018-12-14 | 2018-12-18 | 1,000 | $3.38 | $3.4K | 1,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-12-11 | 2018-12-13 | 2,000 | — | $0 | 47,402 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-12-11 | 2018-12-13 | 611 | $6.11 | $3.7K | 46,791 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Aliski William | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-11-12 | 2018-11-14 | 2,000 | — | $0 | 46,087 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-11-12 | 2018-11-14 | 685 | $7.05 | $4.8K | 45,402 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-10-11 | 2018-10-15 | 2,000 | — | $0 | 44,699 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-10-11 | 2018-10-15 | 612 | $6.46 | $4.0K | 44,087 | SEC↗ |
| Aliski William | Director | A Award deriv | 2018-09-20 | 2018-09-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-09-11 | 2018-09-13 | 685 | $3.93 | $2.7K | 42,699 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-09-11 | 2018-09-13 | 2,000 | — | $0 | 43,384 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-08-13 | 2018-08-15 | 2,000 | — | $0 | 41,976 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-08-13 | 2018-08-15 | 592 | $4.00 | $2.4K | 41,384 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2018-07-25 | 2018-07-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2018-07-25 | 2018-07-27 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Sullivan William A. | Chief Financial Officer | A Award deriv | 2018-07-25 | 2018-07-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | A Award deriv | 2018-07-25 | 2018-07-27 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-07-11 | 2018-07-13 | 2,000 | — | $0 | 40,661 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-07-11 | 2018-07-13 | 685 | $4.15 | $2.8K | 39,976 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-06-11 | 2018-06-13 | 2,000 | — | $0 | 39,267 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-06-11 | 2018-06-13 | 606 | $4.55 | $2.8K | 38,661 | SEC↗ |
| HURWITZ EDWARD | Director | J Other | 2018-05-24 | 2018-05-29 | 25,672 | — | $0 | 27,472 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-05-16 | 2018-05-18 | 3,425 | $5.60 | $19.2K | 37,267 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-05-11 | 2018-05-15 | 2,000 | — | $0 | 41,377 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-05-11 | 2018-05-15 | 685 | $4.90 | $3.4K | 40,692 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-04-11 | 2018-04-13 | 685 | $4.00 | $2.7K | 39,377 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-04-11 | 2018-04-13 | 2,000 | — | $0 | 40,062 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-03-28 | 2018-03-30 | 10,000 | — | $0 | 42,126 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-03-12 | 2018-03-14 | 667 | $4.30 | $2.9K | 32,126 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-03-12 | 2018-03-14 | 2,000 | — | $0 | 32,793 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-02-11 | 2018-02-13 | 2,000 | — | $0 | 30,793 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-02-09 | 2018-04-06 | 2,000 | — | $0 | 27,462 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-02-09 | 2018-04-06 | 733 | $3.95 | $2.9K | 26,729 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-01-11 | 2018-04-06 | 2,000 | — | $0 | 26,253 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-01-11 | 2018-04-06 | 791 | $4.30 | $3.4K | 25,462 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2018-01-11 | 2018-01-16 | 855 | $4.30 | $3.7K | 28,793 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2018-01-11 | 2018-01-16 | 2,000 | — | $0 | 29,648 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | F Tax w/h | 2017-12-11 | 2018-04-06 | 3,395 | $3.75 | $12.7K | 24,253 | SEC↗ |
| Feinsod Matthew | Interim Chief Medical Office | A Award | 2017-09-14 | 2017-09-15 | 10,000 | — | $0 | 27,648 | SEC↗ |
| Sullivan William A. | Chief Financial Officer | A Award deriv | 2017-08-07 | 2017-08-09 | 135,000 | — | $0 | 135,000 | SEC↗ |
| BULLOCK LAWRENCE E | Chief Financial Officer | A Award deriv | 2017-08-03 | 2017-08-09 | 4,168 | — | $0 | 4,168 | SEC↗ |
| Ashe Andrew D. | General Counsel | A Award deriv | 2017-08-01 | 2017-08-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Potter Stephen W | See Remarks | A Award deriv | 2017-07-17 | 2017-07-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2017-07-17 | 2017-07-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Goldstein Michael H. | Chief Medical Officer | A Award deriv | 2017-07-17 | 2017-07-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2017-07-17 | 2017-07-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise deriv | 2017-04-24 | 2017-04-26 | 91 | — | $0 | 0 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise deriv | 2017-04-24 | 2017-04-26 | 328 | — | $0 | 0 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise deriv | 2017-04-24 | 2017-04-26 | 11,476 | — | $0 | 0 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise | 2017-04-24 | 2017-04-26 | 101 | — | $0 | 40,181 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise | 2017-04-24 | 2017-04-26 | 3,559 | — | $0 | 1,404,515 | SEC↗ |
| ORONSKY ARNOLD L | Director | X Exercise | 2017-04-24 | 2017-04-26 | 28 | — | $0 | 11,208 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Rosen James | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ORONSKY ARNOLD L | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Goldstein Michael H. | Chief Medical Officer | A Award deriv | 2016-12-01 | 2016-12-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Magovcevic Ivana | Director | P Buy | 2016-11-16 | 2016-11-17 | 3,000 | $9.63 | $28.9K | 3,000 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | S Sale | 2016-11-01 | 2016-11-02 | 1,000 | $7.05 | $7.0K | 20,400 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise deriv | 2016-10-19 | 2016-10-21 | 1,000 | — | $0 | 29,511 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise deriv | 2016-10-19 | 2016-10-27 | 10,000 | — | $0 | 20,511 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise | 2016-10-19 | 2016-10-21 | 1,000 | $0.35 | $350 | 12,400 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise | 2016-10-19 | 2016-10-27 | 10,000 | $0.35 | $3.5K | 21,400 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | P Buy | 2016-09-22 | 2016-09-26 | 1,700 | $8.87 | $15.1K | 1,700 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | P Buy | 2016-09-22 | 2016-09-26 | 1,300 | $8.87 | $11.5K | 3,000 | SEC↗ |
| Potter Stephen W | See Remarks | P Buy | 2016-09-20 | 2016-09-27 | 400 | $8.69 | $3.5K | 1,400 | SEC↗ |
| BULLOCK LAWRENCE E | Chief Financial Officer | P Buy | 2016-09-19 | 2016-09-20 | 10,000 | $8.75 | $87.5K | 10,000 | SEC↗ |
| Potter Stephen W | See Remarks | P Buy | 2016-09-16 | 2016-09-27 | 1,000 | $8.97 | $9.0K | 1,000 | SEC↗ |
| Washer Susan B. | See Remarks | M Exercise deriv | 2016-08-29 | 2016-08-30 | 5,328 | — | $0 | 0 | SEC↗ |
| Washer Susan B. | See Remarks | M Exercise | 2016-08-29 | 2016-08-30 | 5,328 | $3.50 | $18.6K | 20,328 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | G Gift | 2016-08-22 | 2016-10-21 | 500 | — | $0 | 11,400 | SEC↗ |
| VANLENT ANNE | Director | A Award deriv | 2016-08-17 | 2016-08-18 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Washer Susan B. | See Remarks | A Award deriv | 2016-07-07 | 2016-07-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BULLOCK LAWRENCE E | Chief Financial Officer | A Award deriv | 2016-07-07 | 2016-07-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Potter Stephen W | See Remarks | A Award deriv | 2016-07-07 | 2016-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2016-07-07 | 2016-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Chulay Jeffrey D. | See Remarks | A Award deriv | 2016-07-07 | 2016-07-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise deriv | 2016-05-25 | 2016-05-26 | 2,000 | — | $0 | 2,028 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise | 2016-05-25 | 2016-05-26 | 2,000 | $3.50 | $7.0K | 11,900 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise deriv | 2016-05-11 | 2016-05-26 | 4,000 | — | $0 | 4,028 | SEC↗ |
| Chulay Jeffrey D. | VP and Chief Medical Officer | M Exercise | 2016-05-11 | 2016-05-26 | 4,000 | $3.50 | $14.0K | 9,900 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| PEACOCK BRUCE | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| Rosen James | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| ORONSKY ARNOLD L | Director | A Award deriv | 2015-11-19 | 2015-12-04 | 6,200 | — | $0 | 6,200 | SEC↗ |
| Potter Stephen W | See Remarks | A Award deriv | 2015-07-21 | 2015-07-23 | 51,000 | — | $0 | 51,000 | SEC↗ |
| BULLOCK LAWRENCE E | Chief Financial Officer | A Award deriv | 2015-07-21 | 2015-07-23 | 37,000 | — | $0 | 37,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2015-07-21 | 2015-07-23 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Washer Susan B. | President and CEO | A Award deriv | 2015-07-21 | 2015-07-23 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Chulay Jeffrey D. | See Remarks | A Award deriv | 2015-07-21 | 2015-07-23 | 71,000 | — | $0 | 71,000 | SEC↗ |
| Potter Stephen W | See Remarks | A Award deriv | 2015-07-21 | 2015-08-24 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2015-07-21 | 2015-08-24 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Shearman Mark S | Chief Scientific Officer | A Award deriv | 2015-06-01 | 2015-06-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| PEACOCK BRUCE | Director | A Award deriv | 2015-03-18 | 2015-03-20 | 9,375 | — | $0 | 9,375 | SEC↗ |
| GLAXOSMITHKLINE PLC | Other | S Sale | 2015-02-23 | 2015-02-24 | 503,150 | $22.00 | $11.07M | 1,436,448 | SEC↗ |
| Potter Stephen W | VP and Chief Business Office | A Award deriv | 2015-01-29 | 2015-02-02 | 131,049 | — | $0 | 131,049 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | M Exercise deriv | 2015-01-23 | 2015-01-26 | 1,996 | — | $0 | 115,972 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | S Sale | 2015-01-23 | 2015-01-26 | 1,996 | $24.90 | $49.7K | 0 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | M Exercise | 2015-01-23 | 2015-01-26 | 1,996 | $4.90 | $9.8K | 1,996 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | M Exercise deriv | 2014-12-22 | 2014-12-23 | 9,000 | — | $0 | 117,968 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | M Exercise | 2014-12-22 | 2014-12-23 | 9,000 | $4.90 | $44.1K | 9,000 | SEC↗ |
| Menichella Daniel L | V.P. & Chief Business Office | S Sale | 2014-12-22 | 2014-12-23 | 9,000 | $20.83 | $187.5K | 0 | SEC↗ |
| HURWITZ EDWARD | Director | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| Koenig Scott | Director | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| Magovcevic Ivana | Director | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| ORONSKY ARNOLD L | Director, 10% Owner | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| Rosen James | Director, 10% Owner | A Award deriv | 2014-12-19 | 2014-12-23 | 4,688 | — | $0 | 4,688 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | S Sale | 2014-12-18 | 2015-02-12 | 12,000 | $21.01 | $252.1K | 1,939,598 | SEC↗ |
| GLAXOSMITHKLINE PLC | 10% Owner | S Sale | 2014-12-17 | 2015-02-12 | 8,000 | $21.00 | $168.0K | 1,951,598 | SEC↗ |